WA House - Session - Afternoon
(April 16, 2019)

Tuesday April 16, 2019 1:00 PM
Washington State House of Representatives Logo

The Washington State House of Representatives (WA House) convenes sessions to read, debate, amend, and vote on legislation.

Observations

On Tuesday April 16th, the House called SB 5298 up for its second reading allowing floor amendments to be proposed, debated, and voted upon.

  • See Cannabis Observer’s committee report cutoff summary for SB 5298 – “Regarding labeling of marijuana products” (videapril 16o):
    • 5298-S.E AMH COG H2727.1 was adopted from the Commerce and Gaming Committee, the amendment:
      • (1) Removes the requirement that a structure or function claim included on any Department of Health (DOH) compliant marijuana product label, or a claim that describes a product’s psychoactive effect included on any marijuana product label, be substantiated.
      • (2) Requires a structure or function claim included on any DOH compliant marijuana product label, or a claim that describes a product’s psychoactive effect included on any marijuana product label, to include a disclaimer that states such claims: (a) have not been evaluated by the State of Washington; and (b) are not intended to diagnose, treat, cure, or prevent any disease.
      • (3) Removes “relief” from the list of example marijuana product label terms that may be used to describe the product’s intended role in maintaining a structure or function of the body.
      • (4) Exempts drug and pharmaceutical products approved by the United States Food and Drug Administration from the marijuana product labeling requirements in the section.
    • 5298-S.E AMH ENGR H2727.E is the adopted and engrossed text for the amendment above.
    • 5298-S.E AMH DAVI RAYM 041, by Representative Lauren Davis was also adopted and engrossed into the bill. The change:
      • (1) Removes example terms that Department of Health compliant marijuana products may include on a product label that describes the product’s intended role in maintaining a structure or function of the body.
      • (2) Provides that a warning (rather than a claim) describing the psychoactive effect of a marijuana product is allowed on the product label.
      • (3) Removes the provision that allows a marijuana product label to contain a legal claim related to any non-marijuana ingredients in the product.
  • After amending, House rules were suspended to jump to the bill’s third reading and vote. ESSB 5298 was passed by the House by a vote of 88 yeas, 10 nays, no absent or excused. Read the final House Bill Report and the updated Senate Bill Report.
  • The bill will be returned to its house of origin for concurrence, dispute, or conference.

On Tuesday April 16th, SB 5605 was passed by the House with a vote of 68 yeas, 29 nays, and no absent or excused.

Engagement Options

In-Person

Washington State House of Representatives, Sid Snyder Avenue Southwest, Olympia, WA, USA

Information Set